CN103534595B - 用于监测抗凝疗法的方法 - Google Patents

用于监测抗凝疗法的方法 Download PDF

Info

Publication number
CN103534595B
CN103534595B CN201280021851.3A CN201280021851A CN103534595B CN 103534595 B CN103534595 B CN 103534595B CN 201280021851 A CN201280021851 A CN 201280021851A CN 103534595 B CN103534595 B CN 103534595B
Authority
CN
China
Prior art keywords
factor
plasma
reagent
blood plasma
fiix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201280021851.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN103534595A (zh
Inventor
P·T·昂达森
B·R·古德穆德斯多特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Detective Diagnostic Cos
Original Assignee
Detective Diagnostic Cos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Detective Diagnostic Cos filed Critical Detective Diagnostic Cos
Publication of CN103534595A publication Critical patent/CN103534595A/zh
Application granted granted Critical
Publication of CN103534595B publication Critical patent/CN103534595B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201280021851.3A 2011-03-08 2012-03-08 用于监测抗凝疗法的方法 Active CN103534595B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS050010 2011-03-08
IS050010A IS2809B (is) 2011-03-08 2011-03-08 Blóðstorkumæling
PCT/IS2012/050005 WO2012120546A2 (en) 2011-03-08 2012-03-08 Method for monitoring anticoagulant therapy

Publications (2)

Publication Number Publication Date
CN103534595A CN103534595A (zh) 2014-01-22
CN103534595B true CN103534595B (zh) 2016-03-09

Family

ID=46682867

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280021851.3A Active CN103534595B (zh) 2011-03-08 2012-03-08 用于监测抗凝疗法的方法

Country Status (9)

Country Link
US (2) US9234902B2 (https=)
EP (1) EP2684056B1 (https=)
CN (1) CN103534595B (https=)
DK (1) DK2684056T3 (https=)
ES (1) ES2636318T3 (https=)
IN (1) IN2013MN01890A (https=)
IS (1) IS2809B (https=)
RU (1) RU2607658C2 (https=)
WO (1) WO2012120546A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2944909A1 (en) 2014-04-04 2015-10-08 Bloodworks Routine laboratory and point-of-care (poc) testing for hemostasis
CN106574922B (zh) * 2014-05-05 2020-06-05 美国血液技术公司 用于检测纤维蛋白溶解和纤溶亢进的方法学和试剂
SE540132C2 (sv) * 2014-05-22 2018-04-10 Zafena Ab Analysmetod för bestämning av antikoagulanter i blod eller blodplasma
CN106461327B (zh) 2014-06-09 2019-12-13 泰尔茂比司特公司 冻干法
JP6871673B2 (ja) * 2015-03-31 2021-05-12 学校法人東日本学園 血液検体を判定するための方法、装置及びコンピュータプログラム、並びに血液検体分析装置
WO2016170944A1 (ja) * 2015-04-24 2016-10-27 公立大学法人奈良県立医科大学 血液検体の凝固能の評価方法、並びにその方法に用いるための試薬、試薬キット及び装置
JP6844890B2 (ja) * 2016-01-07 2021-03-17 藤森工業株式会社 採血管、試薬及びそれらを利用した血液性状分析方法
RU2655302C1 (ru) * 2017-05-15 2018-05-24 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования эффективности антикоагулянтной терапии у больных с фибрилляцией предсердий, перенесших инсульт
RU2660706C1 (ru) * 2017-09-26 2018-07-09 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) Скрининг-тест определения контактного пути коагуляции (СТОКПК)
JP7110360B2 (ja) 2017-10-09 2022-08-01 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥方法
CN109459420B (zh) * 2018-12-29 2021-06-04 华南师范大学 一种水体中二/三价铁离子的检测方法
CN113614477B (zh) 2019-03-14 2023-04-28 泰尔茂比司特生物技术有限公司 冷冻干燥装载托盘组件及系统
CN110361531B (zh) * 2019-08-02 2023-04-11 天津医科大学总医院 一种检测微粒促凝活性的实验方法
MX2022004558A (es) * 2019-10-17 2023-03-02 Nova Biomedical Corp Aparato de ensayo de coagulacion y metodos del mismo.
CN114544983A (zh) * 2022-02-28 2022-05-27 南京可诺医疗技术有限公司 一种凝血与血小板功能分析仪用正常值质控品的制备方法
CN114778858A (zh) * 2022-06-23 2022-07-22 深圳市帝迈生物技术有限公司 一种狼疮抗凝物检测试剂盒
CN116840175A (zh) * 2023-07-17 2023-10-03 美迪西普胜医药科技(上海)有限公司 一种注射用重组人凝血因子ⅸ促凝特性的体外检测方法
WO2025132651A1 (en) * 2023-12-20 2025-06-26 Pentapharm Ag Method for analyzing a blood sample with respect to a hemostatic regulator
WO2025186634A1 (en) 2024-03-04 2025-09-12 Fiix Diagnostics Method and kit for monitoring anticoagulant therapy
US12405281B1 (en) 2024-03-04 2025-09-02 Fiix Diagnostics Method and kit for monitoring anticoagulant therapy

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007491A1 (en) * 1991-10-04 1993-04-15 Board Of Regents Of The University Of Nebraska A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
CN1255637A (zh) * 1998-09-03 2000-06-07 希森美康株式会社 抗凝血剂及血液检查方法
WO2004102202A1 (en) * 2003-05-16 2004-11-25 National Institute For Biological Standards And Control (Nibsc) Activation mixture
CN1856710A (zh) * 2003-09-22 2006-11-01 荷玛特克斯研究有限公司 测定促凝血磷脂的方法
CN1952169A (zh) * 2005-10-18 2007-04-25 上海太阳生物技术有限公司 临床检验凝血酶原时间(pt)测定体外诊断试剂盒
CN101221189A (zh) * 2007-01-12 2008-07-16 上海太阳生物技术有限公司 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒
CN101526538A (zh) * 2008-03-09 2009-09-09 上海长岛生物技术有限公司 液体白陶土aptt试剂的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238873A (https=) * 1958-05-16
US3395210A (en) * 1964-02-07 1968-07-30 Warner Lambert Pharmaceutical Lyophilized diagnostic reagent for the determination of blood coagulation factors
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE3413311A1 (de) 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
US5447440A (en) * 1993-10-28 1995-09-05 I-Stat Corporation Apparatus for assaying viscosity changes in fluid samples and method of conducting same
US6194394B1 (en) 1998-07-01 2001-02-27 Sigma-Aldrich Co. Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays
SE0303249D0 (sv) * 2003-12-02 2003-12-02 Inst Polymerutveckling Ab Hematocrit and analyte concentration determination
EP2177624A1 (en) 2008-10-02 2010-04-21 Siemens Healthcare Diagnostics Products GmbH Blood coagulation assays

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993007491A1 (en) * 1991-10-04 1993-04-15 Board Of Regents Of The University Of Nebraska A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
CN1255637A (zh) * 1998-09-03 2000-06-07 希森美康株式会社 抗凝血剂及血液检查方法
WO2004102202A1 (en) * 2003-05-16 2004-11-25 National Institute For Biological Standards And Control (Nibsc) Activation mixture
CN1856710A (zh) * 2003-09-22 2006-11-01 荷玛特克斯研究有限公司 测定促凝血磷脂的方法
CN1952169A (zh) * 2005-10-18 2007-04-25 上海太阳生物技术有限公司 临床检验凝血酶原时间(pt)测定体外诊断试剂盒
CN101221189A (zh) * 2007-01-12 2008-07-16 上海太阳生物技术有限公司 一种用于测定活化部分凝血活酶时间aptt的体外诊断试剂盒
CN101526538A (zh) * 2008-03-09 2009-09-09 上海长岛生物技术有限公司 液体白陶土aptt试剂的制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin;P.A.Owren，et al.;《Scandinavian Journal of Clinical & Laboratory Investigation》;19511231;第3卷(第3期);第203-204页，附图4 *
Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy;I.M. Costa，et al.;《Biomedicine & Pharmacotherapy》;20091216;第64卷(第2期);摘要，第130页右栏第9-15行 *
抗凝剂浓度不同血液的血细胞计数仪分析结果;方蓉 等;《临床检验杂志》;20011231;第19卷(第2期);全文 *

Also Published As

Publication number Publication date
US9234902B2 (en) 2016-01-12
IN2013MN01890A (https=) 2015-09-25
EP2684056B1 (en) 2017-05-03
EP2684056A2 (en) 2014-01-15
CN103534595A (zh) 2014-01-22
IS2809B (is) 2012-10-15
RU2607658C2 (ru) 2017-01-10
WO2012120546A2 (en) 2012-09-13
US20160108457A1 (en) 2016-04-21
US20120231485A1 (en) 2012-09-13
WO2012120546A3 (en) 2012-11-29
DK2684056T3 (en) 2017-07-10
ES2636318T3 (es) 2017-10-05
RU2013144950A (ru) 2015-04-20

Similar Documents

Publication Publication Date Title
CN103534595B (zh) 用于监测抗凝疗法的方法
Lebreton et al. Thrombin generation and cirrhosis: state of the art and perspectives
Favaloro et al. The new oral anticoagulants and the future of haemostasis laboratory testing
CA2623142C (en) Methods for a global assay of coagulation and fibrinolysis
ES2599929T3 (es) Método diagnóstico in vitro para evaluar la enfermedad de von Willebrand y un mayor riesgo hemorrágico asociado con la enfermedad de von Willebrand y los trastornos adquiridos o congénitos de la función trombocítica
JP2004518111A (ja) 包括的な凝固性および止血能を判定するための方法
CA2333890A1 (en) Corn trysin inhibitor stabilizes blood-derived plasma and improves sensitivity of plasma clotting assays
CN103688177B (zh) 狼疮抗凝物检测用血液凝固时间的测定方法
US20100227346A1 (en) Activation Mixture
US20110177541A1 (en) Method for adjusting the coagulation time in calibrator or control plasmas
Dong et al. Variations among normal individuals in the cleavage of endothelial‐derived ultra‐large von Willebrand factor under flow
CN109082458B (zh) 一种血栓弹力图法定量检测口服凝血因子Xa抑制剂试剂盒及其制备方法
Alfirević et al. Hypercoagulable state, pathophysiology, classification and epidemiology.
EP2405274A1 (en) Monitoring anticoagulant therapy and identifying reversible direct factor Xa inhibitors
US12405281B1 (en) Method and kit for monitoring anticoagulant therapy
US20250355004A1 (en) Method and kit for monitoring anticoagulant therapy
Asmis Coagulation factor concentrates
Hellstern Composition of plasma
Mendelsohn et al. Effects of platelets and platelet‐derived material on the activated partial thromboplastin time (Cephotest®) coagulation test
WO2015073418A2 (en) Methods and assays for factor viii activity
Castellone Overview of hemostasis and platelet physiology
Hedner et al. Recent advances in clot biology and assessment of clotting
Kuczaj et al. Longitudinal Assessment of Thrombin Generation Using Calibrated Automated Thrombography in Patients with Continuous-Flow Left Ventricular Assist Devices over a Five-Year Period
JP2008530992A (ja) 血液または血漿の試料の総凝固活性の測定方法
Caldwell Digestive Health Center of Excellence University of Virginia Medical Center Box 800708, Charlottesville, VA 22908-0708 Arun J. Sanyal, MD Division of GI/Hepatology and Nutrition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant